Document is current
Any future updates will be listed below
-
Authors
van de Wiel, H. J.
Stuiver, M. M.
May, A. M.
van Grinsven, S.
Aaronson, N. K.
Retèl, V. P.
Oldenburg, H. S. A.
van der Poel, H. G.
Horenblas, S.
van Harten, W. H.
Groen, W. G.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (NKI 2015-7904)
- License Information
-
More Information
Article History
Received: 22 May 2018
Accepted: 10 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: This trial has been approved by the institutional review boards of the NKI, Medical Ethics Review Committee of Stichting Nederlands Kanker Instituut - The Antoni van Leeuwenhoek Hospital (METC AVL) and subsequent approval for participation of The Rijnstate Hospital was obtained from the board of directors. Prior to participation, patients sign an informed consent (see attachment).List of participating centres:Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.Rijnstate Hospital, Arnhem, the Netherlands.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
